Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 16 Feb 2023
Many physicians have encountered one or more serious or potentially dangerous patients over the years, and according to Medscape research, patient trust has declined.
Read Full NewsDavid Tom Cooke, MD, reviewed the importance of shared decision making as it relates to risk and benefit of cancer screening, as well as in more refined invasive care options.
Friedberg explains how an emphasis on physical fitness prior to and after surgery can significantly better long-term outcomes.
Bakhos explains the ideal patient population and strategies inherent to LVRS success.
The chief medical officer at the Parkinson’s Foundation detailed how mood and behavioral symptoms shape quality of life in Parkinson disease and how clinicians can better identify and manage them.
IntraBio reported that levacetylleucine showed symptom improvement in the phase 3 IB1001-303 study for ataxia-telangiectasia, and it intends to proceed with regulatory submissions in multiple regions.
A Phase 1 study in healthy lactating women found that a single 10‑mg dose of zavegepant nasal spray was generally safe, well tolerated, and resulted in minimal infant exposure through breast milk.
Julie Khlevner, MD, AGAF, highlights that FDA approval of linaclotide provides the first pharmacologic therapy for pediatric IBS-C.
1.
Novel probes to label macrophages associated with cancer progression using a selective dye
2.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
3.
Tumor characteristics found to differ for melanomas in children, teens and young adults
4.
UK government can save lives and smash inequalities by changing prostate cancer guidelines, say experts
5.
Study shows supervised exercise improves strength, physical performance in patients with advanced breast cancer
1.
Colorectal Cancer Incidence Trends: A Growing Concern in 2024 and 2025
2.
Intrapancreatic Fat, Pancreatitis, and Cancer: Role of Cancer-Associated Fibroblasts
3.
Understanding Adenomyosis: The Role of Ultrasound in Diagnosis Introduction
4.
How Bispecific Antibodies are Redefining Medical Oncology in the US - A 2025 Review
5.
Liposomal Doxorubicin and Mitomycin in Modern Cancer Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
2.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
3.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
4.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
5.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge